Works by Geyer, Susan M.


Results: 33
    1

    Depth of Response From Fixed‐Duration Treatment Is Associated With Superior Survival in Waldenstrom Macroglobulinemia.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 6, p. 980, doi. 10.1002/ajh.27663
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Perera, Nirosha D.;
    • Sarosiek, Shayna;
    • Gustine, Joshua;
    • Ramirez‐Gamero, Andres;
    • Varettoni, Marzia;
    • Tedeschi, Alessandra;
    • Cavalloni, Chiara;
    • Frustaci, Anna Maria;
    • Pederson, Levi D.;
    • Zanwar, Saurabh S.;
    • Kapoor, Prashant;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Geyer, Susan M.;
    • Treon, Steven P.;
    • Castillo, Jorge J.
    Publication type:
    Article
    2

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    3
    4

    The clinical spectrum of Castleman's disease.

    Published in:
    American Journal of Hematology, 2012, v. 87, n. 11, p. 997, doi. 10.1002/ajh.23291
    By:
    • Dispenzieri, Angela;
    • Armitage, James O.;
    • Loe, Matt J.;
    • Geyer, Susan M.;
    • Allred, Jake;
    • Camoriano, John K.;
    • Menke, David M.;
    • Weisenburger, Dennis D.;
    • Ristow, Kay;
    • Dogan, Ahmet;
    • Habermann, Thomas M.
    Publication type:
    Article
    5

    A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
    By:
    • Dispenzieri, Angela;
    • Wiseman, Gregory A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Kumar, Shaji K.;
    • Buadi, Francis;
    • Dingli, David;
    • Laumann, Krista M.;
    • Allred, Jake;
    • Geyer, Susan M.;
    • Litzow, Mark R.;
    • Gastineau, Dennis A.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Ansell, Stephen M.;
    • Porrata, Luis;
    • Elliott, Michelle A.;
    • Johnston, Patrick B.;
    • Hogan, William J.;
    • Gertz, Morie A.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 11, p. 1677, doi. 10.1002/cncr.28642
    By:
    • Cohen, Jonathon B.;
    • Geyer, Susan M.;
    • Lozanski, Gerard;
    • Zhao, Weiqiang;
    • Heerema, Nyla A.;
    • Hall, Nathan C.;
    • Nagar, Veena A.;
    • Hemminger, Jessica A.;
    • Jones, Jeffrey A.;
    • Porcu, Pierluigi;
    • Christian, Beth A.;
    • Baiocchi, Robert A.;
    • Maddocks, Kami J.;
    • Flynn, Joseph M.;
    • Devine, Steven M.;
    • Blum, Kristie A.
    Publication type:
    Article
    11

    Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.

    Published in:
    2019
    By:
    • Haller, Michael J.;
    • Long, S. Alice;
    • Blanchfield, J. Lori;
    • Schatz, Desmond A.;
    • Skyler, Jay S.;
    • Krischer, Jeffrey P.;
    • Bundy, Brian N.;
    • Geyer, Susan M.;
    • Warnock, Megan V.;
    • Miller, Jessica L.;
    • Atkinson, Mark A.;
    • Becker, Dorothy J.;
    • Baidal, David A.;
    • DiMeglio, Linda A.;
    • Gitelman, Stephen E.;
    • Goland, Robin;
    • Gottlieb, Peter A.;
    • Herold, Kevan C.;
    • Marks, Jennifer B.;
    • Moran, Antoinette
    Publication type:
    journal article
    12
    13
    14

    Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals.

    Published in:
    Science Translational Medicine, 2021, v. 13, n. 583, p. 1, doi. 10.1126/scitranslmed.abc8980
    By:
    • Sims, Emily K.;
    • Bundy, Brian N.;
    • Stier, Kenneth;
    • Serti, Elisavet;
    • Lim, Noha;
    • Long, S. Alice;
    • Geyer, Susan M.;
    • Moran, Antoinette;
    • Greenbaum, Carla J.;
    • Evans-Molina, Carmella;
    • Herold, Kevan C.;
    • DiMeglio, Linda A.;
    • Gitelman, Stephen E.;
    • Gottlieb, Peter A.;
    • Marks, Jennifer B.;
    • Moore, Wayne;
    • Rodriguez, Henry;
    • Russell, William E.;
    • Schatz, Desmond;
    • Tsalikian, Eva
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma.

    Published in:
    Cancer (0008543X), 2010, v. 116, n. 12, p. 2993, doi. 10.1002/cncr.25114
    By:
    • Geyer, Susan M.;
    • Morton, Lindsay M.;
    • Habermann, Thomas M.;
    • Allmer, Cristine;
    • Davis, Scott;
    • Cozen, Wendy;
    • Severson, Richard K.;
    • Lynch, Charles F.;
    • Wang, Sophia S.;
    • Maurer, Matthew J.;
    • Hartge, Patricia;
    • Cerhan, James R.
    Publication type:
    Article
    21
    22

    Thalidomide therapy in adult patients with myelodysplastic syndrome.

    Published in:
    Cancer (0008543X), 2006, v. 107, n. 4, p. 767, doi. 10.1002/cncr.22047
    By:
    • Moreno-Aspitia, Alvaro;
    • Colon-Otero, Gerardo;
    • Hoering, Antje;
    • Tefferi, Ayalew;
    • Niedringhaus, Robert D.;
    • Vukov, Allen;
    • Li, Chin-Yang;
    • Menke, David M.;
    • Geyer, Susan M.;
    • Alberts, Steven R.
    Publication type:
    Article
    23
    24
    25
    26

    A phase II trial of imatinib in patients with refractory/relapsed myeloma.

    Published in:
    Leukemia & Lymphoma, 2006, v. 47, n. 1, p. 39, doi. 10.1080/10428190500271269
    By:
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Geyer, Susan M.;
    • Greipp, Phillip R.;
    • Rajkumar, S. Vincent;
    • Kimlinger, Teresa;
    • Lust, John A.;
    • Fonseca, Rafael;
    • Allred, Jacob;
    • Witzig, Thomas E.
    Publication type:
    Article
    27

    Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance.

    Published in:
    American Journal of Clinical Pathology, 2022, v. 158, n. 4, p. 530, doi. 10.1093/ajcp/aqac083
    By:
    • Jevremovic, Dragan;
    • Nanaa, Ahmad;
    • Geyer, Susan M;
    • Timm, Michael;
    • Azouz, Haya;
    • Hengel, Cynthia;
    • Reberg, Alexander;
    • He, Rong;
    • Viswanatha, David;
    • Salama, Mohamad E;
    • Shi, Min;
    • Olteanu, Horatiu;
    • Horna, Pedro;
    • Otteson, Gregory;
    • Greipp, Patricia T;
    • Xie, Zhuoer;
    • Alkhateeb, Hassan B;
    • Hogan, William;
    • Litzow, Mark;
    • Patnaik, Mrinal M
    Publication type:
    Article
    28
    29
    30
    31

    Thalidomide treatment in myelofibrosis with myeloid metaplasia.

    Published in:
    British Journal of Haematology, 2002, v. 117, n. 2, p. 288, doi. 10.1046/j.1365-2141.2002.03443.x
    By:
    • Elliott, Michelle A;
    • Mesa, Ruben A;
    • Li, Chin-Yang;
    • Hook, C. Christopher;
    • Ansell, Stephen M;
    • Levitt, Ralph M;
    • Geyer, Susan M;
    • Tefferi, Ayalew
    Publication type:
    Article
    32
    33